According to the Zhitong Finance App, Wanfu Biotech (300482.SZ) released its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 1,569 billion yuan, a year-on-year decrease of 7.18%. Net profit attributable to shareholders of listed companies was 134 million yuan, an increase of 0.10% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 858.545 million yuan, an increase of 3.89% over the previous year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.